Careggi University Hospital
Careggi University Hospital is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Randomized, open-label, multicenter phase 3 study to assess the efficacy and safety of GIVinostat versus hydroxyurea IN JAK2V617F-positive high-risk Polycythemia Vera patients: the GIV-IN PV TRIAL
Sponsor Italfarmaco S.p.A.
- Start (EU)
- Latest update
- Estimated end
Long-term study evaluating the effect of givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
Sponsor Italfarmaco S.p.A.
- Start (EU)
- Latest update
- Estimated end
Multicenter, Phase Ib/IIa Study on the Safety and Efficacy of Autologous Peptide-coupled Red Blood Cells in Patients with Relapsing Remitting Multiple Sclerosis
Sponsor Cellerys AG
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Careggi University Hospital?
The 2026-10-09 snapshot links Careggi University Hospital to 3 distinct CTIS trials. Recorded services include Analysis of JAK2V617F gene mutation and molecular markers predictive of clinical benefit, Laboratory services, MRI recording for site 1-01, Preparation of blood product for further IMP manufacturing (site 1-01). These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Careggi University Hospital?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Careggi University Hospital conducted?
The linked trials record locations in 12 countries, including Italy, Germany, Austria, Bulgaria, Czechia. These are trial locations, not confirmed office locations or countries where Careggi University Hospital delivered services.
What can this page tell me about Careggi University Hospital's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Careggi University Hospital. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Careggi University Hospital